Protalix BioTherapeutics, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Hackensack, NJ
PLX chart
What traders are saying about $PLX
Latest postsProtalix BioTherapeutics, Inc. news
- Protalix BioTherapeutics, Inc. (PLX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference
Yahoo Finance ·
- Guerrilla RF Heads These 3 Top Penny Stocks To Watch
Yahoo Finance ·
- Protalix BioTherapeutics, Inc. Stock Price Today | PLX Live Chart & News
Traders Union ·
- Protalix BioTherapeutics, Inc. (PLX) Stock Price Prediction for 2026, 2030-2040
Traders Union ·
- 3 Oil And Gas Stocks to Watch as Supply Shock Risks Rise
Yahoo Finance ·
- Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Yahoo Finance ·
- Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
Yahoo Finance ·
- Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- PLX: Elfabrio Estimates Up
Yahoo Finance ·
- Protalix BioTherapeutics Inc (PLX) (Q2 2026) Earnings Call Highlights: Net Income Surges to $3. ...
Yahoo Finance ·
- Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
Yahoo Finance ·
Protalix BioTherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $52.7M | $53.4M | $65.5M | $47.6M |
| Net income | -$6.6M | $2.9M | $8.3M | -$14.9M |
| Diluted EPS | $-0.08 | $0.04 | $0.09 | $-0.31 |
| Total assets (year end) | $82.3M | $73.4M | $84.4M | $55.8M |
| Cash and equivalents (year end) | $14.7M | $19.8M | $23.6M | $17.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Protalix BioTherapeutics, Inc.
- Ticker
- PLX (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Hackensack, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1006281
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Frequently asked questions
What exchange is Protalix BioTherapeutics, Inc. listed on?
Protalix BioTherapeutics, Inc. trades on the NYSE under the ticker symbol PLX.
What industry is Protalix BioTherapeutics, Inc. in?
Protalix BioTherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Protalix BioTherapeutics, Inc. headquartered?
Protalix BioTherapeutics, Inc.'s business address on file with the SEC is in Hackensack, NJ.
When does Protalix BioTherapeutics, Inc.'s fiscal year end?
Protalix BioTherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Protalix BioTherapeutics, Inc. report?
Protalix BioTherapeutics, Inc. reported $52.7M in revenue for calendar year 2025, according to its SEC filings.